Schizophrenia Research
Volume 44, Issue 3 , Pages 193-211 , 1 September 2000

Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia

Received 10 May 1999 ,Accepted 17 September 1999.

References 

  1. Adler LE, Pecevich M, Nagamoto H. Bereitschaftspotential in Tardive Dyskinesia. Movement Disorders. 1989;4:105–112
  2. American Psychiatric Association . Diagnostic Manual of Mental Disorders. 4th edition. Washinton, DC: American Psychiatric Press; 1994;
  3. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. Rating scale and standardized examination. Acta Psychiat. Scand. 1996;93:129–143
  4. Chiarenza GA, Papkostopoulos D, Dini M, Cazullo CL. Neurophysiological correlates of psychomotor activity in chronic schizophrenics. Electroencephalogr. Clin. Neurophysiol. 1985;61:218–228
  5. Curtin F, Schulz P. Multiple correlations and Bonferroni correction. Biol. Psychiatry. 1998;44:775–777
  6. Deecke L. Planning, preparation, execution and imagery of volitional action. Cogn. Brain Res. 1996;3:59–64
  7. Deecke L, Lang W, Heller HJ, Hufnagel M, Kornhuber HH. Bereitschaftspotential in patients with unilateral lesions of the supplementary area. J. Neurol. Neurosurg. Psychiatry. 1987;50:1430–1434
  8. Dick JPR, Cantello R, Buruma O, Gioux M, Benecke R, Day BL. The Bereitschaftpotential, l-dopa and Parkinson's disease. Electroencephal. Clin. Neurophysiol. 1987;66:263–274
  9. Dick JPR, Rothwell JC, Day BL, Cantello R, Buruma O, Gioux M, et al.  The Bereitschaftspotential is abnormal in Parkinson's disease. Brain. 1989;112:233–244
  10. Endicott J, Spitzer R, Flies J, et al.  The global assessment scale. Arch. Gen. Psychiatry. 1976;33:766–771
  11. Fetz E. Are movement parameters recognizably coded in the activity of single neurons?. Behav. Brain Res. 1992;15:679–690
  12. Fink M, Bush G, Francis A. Catatonia: a treatable disorder occaisionally recognized. Directions in Psychiatry. 1993;13:1–7
  13. Gelenberg AJ. The catatonic syndrome. Lancet. 1976;2:1339–1341
  14. Gelenberg AJ. Criteria for the diagnosis of catatonia. Am. J. Psychiatry. 1977;134:462–463
  15. Goldberg HL, Finnerty R. Comparison of buspirone in two separate studies. J. Clin. Psychiatry. 1982;43:87–91
  16. Greenblatt D, Franke K, Shader R. Analysis of lorazepam and its glucuronide metabolite by electron-capture gas-liquid chromatography. J. Chromatogr. 1978;146:311–320
  17. Guy W. Assessment Manual for Psychopharmacology. 1976;
  18. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1959;32:50–55
  19. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  20. Hikosaka O, Tanaka M, Sakamoto M, Iwamura Y. Deficits in manipulative behaviors induced by local injections of muscimol in the first somatosensory cortex of the conscious monkey. Brain Res. 1985;325:375–380
  21. Hommer DW, Matsuo V, Wolkowitz O, Chrousos G, Greenblatt DJ, Weingartner H, et al. Benzodiazepine sensitivity in normal human subjects. Arch. Gen. Psychiatry. 1986;43:542–551
  22. Jahanshahi M, Jenkins IH, Brown RG, Marsden CD, Passingham RE, Brooks DJ. Self-initiated versus externally triggered movements. Brain. 1995;118:913–933
  23. Kahlbaum K. Die Katatonie oder das Spannungsirresein. Eine Form psychischer Krankheit. Berlin: Hirschwald; 1878;
  24. Karaman T, Ozkaynak S, Yaltkaya K, Buyukberker C. Bereitschaftspotential in schizophrenia. Br. J. Psychiatry. 1997;171:31–34
  25. Kay SR, Opler LA, Fiszbein A. In: Positive and Negative Syndrome Scale (PANSS) Rating Manual. San Rafael, CA: Social and Behavioral Sciences Documents; 1987;
  26. Kornhuber HH, Deecke L. Hirnpotentialveränderungen beim Menschen vor und nach Willkürbewegungen. Pflügers Archiv. 1964;281:52
  27. Kubota K. Motor cortical muscimol injection disrupts forelimb movement in freely moving monkeys. NeuroReport. 1996;7:2379–2384
  28. Kubota F, Miyata H, Shibata N, Yarita H. A study of motor dysfunction associated with schizophrenia based on analyses of movement-related cerebral potentials and motor conduction time. Biol. Psychiatry. 1999;45:412–416
  29. Kurata K, Hoffman D. Differential effects of muscimol microinjection into dorsal and ventral aspects of the premotor cortex of monkeys. J. Neurophysiology. 1994;71:1151–1164
  30. Lohr JB, Wisniewski AA. In: Movement Disorders: a Neuropsychiatric Approach. New York: Guilford Press; 1987;
  31. MacKinnon CD, Kapur S, Hussey D, Verrier MC, Houle S, Tatton WG. Contributions of the mesial frontal cortex to the premovement potentials associated with intermittent hand movements. Human Brain Mapping. 1996;4:1–22
  32. Marquardt C, Mai N. A computational procedure for movement analysis in handwriting. J. Neurosci. Meth. 1994;52:39–45
  33. Matthew E, Andreason P, Pettigrew K, Carson R, Herscovitch P, King C, et al. Benzodiazepine receptors mediate regional cerebral blood flow changes in the living human brain. Proc. Natl. Acad. Sci. USA. 1995;92:2775–2779
  34. Miller D, Rezai K, Alliger R, Andreasen N. The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia. Biol. Psychiatry. 1997;41:550–559
  35. Northoff G. Katatonie Einführung in die Phänomenologie Klinik und Pathophysiologie eines psychomotorischen Syndroms. Stuttgart: Enke; 1997;
  36. Northoff G, Wenke J, Demisch L, Pflug B. Catatonia: short-term response to lorazepam and dopaminergic metabolism. Psychopharmacology. 1995;122:82–186
  37. Northoff G, Wenke J, Koch A, Eckert J, Pflug B. Ball experiments in akinetic catatonia: deficits of internal initiation and the voluntary generation of movements. Movement Disorders. 1995;12:589–595
  38. Northoff G, Wenke J, Krill W, Pflug B. Ball-experiments in 32 acute akinetic catatonic patients: deficits of internal initiation and generation of movements. Movement Disorders. 1995;10:589–595
  39. Northoff G, Krill W, Eckert J, Russ M, Pflug B. Major differences in subjective experience of akinetic states in catatonic and parkinsonic patients. Cogn. Neuropsychiatry. 1998;3(3):161–178
  40. Northoff G, Koch A, Wenke J, Eckert J, Pflug B, Bogerts B. Catatonia as a psychomotor disease: a rating scale, subtypes and extrapyramidal motor symptoms. Movement Disorders. 1999;14(3):404–416
  41. Northoff G, Braus D, Sartorius A, Khoram-Sefat D, Russ M, Eckert J, et al. Reduced activation and altered laterality in two neuroleptic-naive catatonic patients during a motor task in functional MRI. Psychol. Med. 1999;29:997–1002
  42. Northoff G, Steinke R, Czcervenka C, Krause R, Ulrich S, Danos P, et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J. Neurol. Neurosurg. Psychiatry. 1999;in press
  43. Oldfield RC. The assessment and analysis of handedness: the Edinborough Inventory. Neuropsychologia. 1971;9:97–113
  44. Petrides G, Divadeenam K, Bush G, Francis A. Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. Biol. Psychiatry. 1997;42:375–381
  45. Rosebush P, Furlong B, Mazurek M. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation an response to lorazepam. J. Clin. Psychiatry. 1990;51:357–362
  46. Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiat. Scand. 1970;212:11–19
  47. Singh J, Knight RT. Frontal lobe contribution to voluntary movements in humans. Brain Res. 1990;531:45–54
  48. Singh J, Knight RT, Rosenlicht N, Kotun JM, Beckley DJ, Woods DL. Abnormal premovement brain potentials in schizophrenia. Schizophr. Res. 1992;8:31–41
  49. Taylor M. Catatonia. a review of the behavioral-neurologic syndrome. Neuropsychiat. Neuropsychol. Behav. Neurol. 1990;3:48–72
  50. Wang G, Volkow N, Overall J, Hitzemann R, Pappas N, Pascani K, et al. Reproducibility of regional brain metabolic responses to lorazepam. J. Nucl. Med. 1996;37:1609–1613
  51. Wetzel H, Heuser I, Benkert O. Stupor und affektiver Zustand: Besserung psychomotorischer Störung durch Lorazepam und Wiederkehr der Symptome nach der Gabe von Ro 15-1788. J. Nerv. Ment. Dis. 1987;175:4–6

PII: S0920-9964(99)00189-9

Schizophrenia Research
Volume 44, Issue 3 , Pages 193-211 , 1 September 2000

Article Tools

* Image Usage & Resolution